Sequoia tech legend to step back for medical reasons

May 21, 2012

Michael Moritz, a venture capitalist who provided early backing for firms including Google and Yahoo!, is stepping back from management at Sequoia Capital for medical reasons.

Moritz said in a statement released Monday that he was "diagnosed with a rare medical condition which can be managed but is incurable."

"I've been told that in the next five to 10 years the quality of my life is quite likely to decline," the statement said.

"Right now I feel fitter than ever and I hope that I'll be one of the lucky ones who can live a full life and defy the statisticians. But there is no way of predicting this with certainty and thus for me, life has assumed a different meaning and I am making some adjustments."

Moritz said he would remain chairman and continue to be "deeply involved" in funding new ventures, but would "extract myself from the daily management of Sequoia Capital."

Sequoia has been among the most prominent of the venture firms, backing companies such as Apple, , Oracle and others.

The Welsh-born Moritz joined Sequoia in 1986.

Explore further: Venture investments jump to $9.5B in 1Q

add to favorites email to friend print save as pdf

Related Stories

TechCrunch founder starts venture capital fund

Sep 02, 2011

(AP) -- Michael Arrington, founder of popular tech blog TechCrunch, is starting a venture capital firm with an initial $20 million to invest in the same kinds of startups that TechCrunch often covers.

Immigration chief seeks to reassure Silicon Valley

Feb 22, 2012

(AP) -- The Obama administration's top immigration official said Wednesday he wants to keep more foreign-born high-tech entrepreneurs in the U.S. But to make that happen, he said he needs those entrepreneurs to turn their ...

Professor accused of telling secrets

Jan 16, 2006

A California biotech company has reportedly filed a legal action against a University of Connecticut professor, alleging he disclosed trade secrets.

VCs seek dot-com success stories in India

Mar 24, 2006

Manik Arora of Battery Ventures, the Silicon Valley-based VC that prefers to call itself a "lead institutional investor in its portfolio companies," spends a lot of time researching on Indian Internet ventures these days. ...

Recommended for you

Venture investments jump to $9.5B in 1Q

7 hours ago

Funding for U.S. startup companies soared 57 percent in the first quarter to a level not seen since 2001, as venture capitalists piled more money into an increasing number of deals, according to a report due out Friday.

Weibo IPO below expectations, raises $285.6 mn

Apr 17, 2014

Sina Weibo sold fewer shares than expected in its US IPO which was priced below expectations ahead of a Thursday listing that takes place after tech selloffs on Wall Street.

'Chief Yahoo' David Filo returns to board

Apr 17, 2014

Yahoo announced the nomination of three new board members, including company co-founder David Filo, who earned the nickname and formal job title of "Chief Yahoo."

User comments : 0

More news stories

Under some LED bulbs whites aren't 'whiter than white'

For years, companies have been adding whiteners to laundry detergent, paints, plastics, paper and fabrics to make whites look "whiter than white," but now, with a switch away from incandescent and fluorescent lighting, different ...

Researchers uncover likely creator of Bitcoin

The primary author of the celebrated Bitcoin paper, and therefore probable creator of Bitcoin, is most likely Nick Szabo, a blogger and former George Washington University law professor, according to students ...

Continents may be a key feature of Super-Earths

Huge Earth-like planets that have both continents and oceans may be better at harboring extraterrestrial life than those that are water-only worlds. A new study gives hope for the possibility that many super-Earth ...

Researchers successfully clone adult human stem cells

(Phys.org) —An international team of researchers, led by Robert Lanza, of Advanced Cell Technology, has announced that they have performed the first successful cloning of adult human skin cells into stem ...